NASDAQ: TSBX - Turnstone Biologics Corp. Common Stock

Yield per half year: -78.11%
Dividend yield: 0.00%

Current price
2.68 $
Average price
1.86 $ -30.56%

Price based on EPS
1.65 $ -38.45%
Price according to DCF model (ebitda)
2.07 $ -22.66%
0/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 1.65 $
Current price = 2.68 $ (difference = -38.45%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 2.07 $
Current price = 2.68 $ (difference = -22.66%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -146.83 $
Current price = 2.68 $ (difference = -5 578.75%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription